Tag: Calimmune

King of Prussia’s CSL Behring to Acquire Calimmune for $91M

King of Prussia’s biotherapeutics company CSL Behring is acquiring Calimmune, a clinical-stage biotechnology company, for $91 million, writes Linda Loyd for Philly.com…